___

• KAYNAKLAR
• Thangaratinam S, Langenveld J, Mol BW, Khan KS. Predictionand primary prevention of pre-eclampsia. Best Pract Res Clin Obstet Gynaecol 2011; 25(4): 419-33.
• Enders AC, Carter AM. Review: The evolving placenta:different developmental paths to a hemochorial relationship. Placenta 2012; 33: 92-8.
• Myatt L, Clifton RG, Roberts JM, Spong CY, Hauth JC, VarnerMW et al. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet Gynecol. 2012;120(4):815-22
• Naicker T, Khedun SM, Moodley J, Pijnenborg R. Quantitativeanalysis of trophoblast invasion in preeclampsia. Acta Obstet Gynecol Scand 2003; 82(8): 722-9.
• Lyall F, Robson SC, Bulmer JN. Spiral artery remodelingand trophoblast invasion in preeclampsia and fetal growth restriction: relationship to clinical outcome. Hypertension 2013; 62(6): 1046-54.
• El-Hamedi, Shillito J, Simpson NA, Walker JJ. A prospectiveanalysis of the role of uterine artery Doppler waveform notching in the assessment of at-risk pregnancies. Hypertens Pregnancy 2005; 24(2): 137-45.
• Morris RK, Cnossen JS, Langejans M, Robson SC, Kleijnen J, Ter Riet G, et al. Serum screening with Down’s syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth 2008; 8: 33-52.
• Tancrède S, Bujold E, Giguère Y, Renald MH, Girouard J, Forest JC. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes. JOGC 2015; 37(2): 111-6.
• Spaggiari E, Ruas M, Dreux S, Valat AS, Czerkiewicz I, Guimiot F, et al. Management strategy in pregnancies with elevated second-trimester maternal serum alpha-fetoprotein based on a second assay. AJOG 2013; 208(4): 303.e1-7
• Gagnon A1, Wilson RD, Audibert F, Allen VM, Blight C, Brock JA et al. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can. 2008;30(10):918-49.
• A. Gagnon, R.D. Wilson, F. Audibert, V.M. Allen, C. Blight, J.A.Brock, et al. Obstetrical complications associated with abnormal maternal serum markers analytes. JOGC 2008; 30(10): 918-49.
• Roman A, Desai N, Krantz D, Liu HP, Rosner J, Vohra N,Rochelson B. Maternal serum analytes as predictors of IUGR with different degrees of placental vascular dysfunction. Prenat Diagn 2014; 34(7): 692-8.
• Androutsopoulos G, Gkogkos P, Decavalas G. Mid-trimestermaternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab 2013; 11(2): 102-6.
• Askie LM, Duley L, Henderson-Smart DJ, Stewart LA.Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369(9575): 1791-8.
• Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F,Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 2010; 116(2): 402-14.
• Bujold E, Morency AM, Roberge S, Lacasse Y, Forest JC,Giguere Y. Acetylsalicylic acid for the prevention of preeclampsia and intra-uterine growth restriction in women with abnormal uterine artery Doppler: a systematic review and meta-analysis. JOGC 2009; 31(9): 818-26.
• Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR.Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014;6:CD001059
• Fleischer A, Schulman H, Farmakides G, Bracero L, GrunfeldL, Rochelson B, et al. Uterine artery Doppler velocimetry in 100 pregnant women with hypertension. AJOG 1986; 154(4): 806-13.
• Ay E, Kavak N, Elter K, Gökaslan H, Pekin T: Screening for preeclampsia by using maternal serum inhibin A, βHCG, estriol and AFP levels and uterine artery Doppler in the second trimestr of pregnancy. ANZJOG 2005; 45(4): 283-8.
• Barkehall-Thomas A, Wilson C, Baker L, ni Bhuinneain M, Wallace EM. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin. Acta Obstet Gynecol Scand 2005; 84(8): 743-7.
• El-Baradie SM, Mahmoud M, Makhlouf HH. Elevated serum levelsof interleukin-15, interleukin-16, and human chorionic gonadotropin in women with preeclampsia. J Obstet Gynaecol Can. 2009;31(2):142-8.54